← Back to catalogue

INNO-LiPA HCV 2.0 Amp

FDA UDI

Class II (US FDA UDI)

by Fujirebio Europe

Identity

Trade Name
INNO-LiPA HCV 2.0 Amp FDA UDI
Generic Name
Hepatitis C virus genotyping IVD, kit, nucleic acid technique (NAT) FDA UDI
Model / Reference
81663 FDA UDI

Identifiers

Primary DI / UDI-DI
05414470816637 FDA UDI
PMA Number
P160016 FDA UDI
FDA Product Code
OBF FDA UDI
GMDN Term
Hepatitis C virus genotyping IVD, kit, nucleic acid technique (NAT) FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
866.3170 FDA UDI
Commercial Distribution
Not in Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

INNO-LiPA HCV 2.0 Amp by Fujirebio Europe — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Fujirebio Europe

Sources (1)

  • FDA UDI d1f9da85-a01b-45ca-af5d-ff54f3f52108 37 fields · synced Jun 8, 2026